, GROUP CEO, AMERICAN ONCOLOGY INSTITUTE, ON HIS ENDEAVOUR TO BRING WORLD-CLASS CANCER CARE TO SOUTH-EAST ASIA
|
|
- Norman Cunningham
- 6 years ago
- Views:
Transcription
1 WPP license no. MR/TECH/WPP-76/North/2017 License to post without prepayment Postal Registration No. MCN/242/ Published on 27th of every previous month. Posting date: 30th & 31st of every previous month. Posted at Patrika Channel Sorting Office, Mumbai Registered with Registrar of Newspapers under RNI No. MAHENG/2012/ Total number of pages 48 Aligning business and healthcare in India July 2017 Vol 5 Issue 10 `50 KERALA SPECIAL PRIVATE HEALTHCARE BOOM IT LEVERAGING IT FOR HOME HEALTHCARE BEST OF THE WEST DR LLOYD NAZARETH, GROUP CEO, AMERICAN ONCOLOGY INSTITUTE, ON HIS ENDEAVOUR TO BRING WORLD-CLASS CANCER CARE TO SOUTH-EAST ASIA Published by ITP Publishing India
2 1
3 Asian Voyage Dr Lloyd Nazareth, group CEO, Cancer Treatment Services International, and Vishal Bali, senior advisor, TPG Growth, on creating a protocol-driven oncology network in south-east Asia BY RITA DUTTA When former Fortis group CEO, Vishal Bali, was roped in as a senior advisor and Asia head for the healthcare arm of TPG Growth in April 2014, all eyes were on the lucrative deals that the PE firm would start scooping up in Asia. But TPG Growth, the middle market and growth-equity investment vehicle of TPG, was in no hurry. News that TPG Growth could be investing in Cancer Treatment Services International (CTSI) streamed in the second quarter of 2015 and gained momentum after Dr Lloyd Nazareth, Bali s team mate and COO in Wockhardt Hospitals and Fortis Healthcare, joined TPG Growth as a consultant. In January 2016, TPG Growth made a significant investment in Asiri Healthcare, Sri Lanka s largest healthcare delivery network. However, in India it was only in April 2016, after evaluating an array of potential investments, TPG Growth announced an acquisition of 65% stake in for $33 million (Rs 220 crore) in CTSI. Pittsburgh-based CTSI forayed in India in 2012 with threepronged business segments. Its core brand is American Oncology Institute (AOI) that is pivotted around specialised oncology care. The other two segments are Citizens Hospital, which is a multi speciality hospital in Hyderabad, and AmPath, which is a pathology diagnostics provider with a niche focus on oncology diagnostics. CTSI was founded by renowned oncologists, Dr Jeffery Shogan and Dr Stanley Marks, along with a host of other clinicians from the University of Pittsburgh Medical Centre (UPMC), one of the leading oncology centres in the US. Their endeavour was to make innovative and protocol-driven cancer treatment available to patients outside of the US, particularly in the developing world. They teamed up with Dr RP Raju, a radiation oncologist, to start the 1. Dr Lloyd Nazareth and Vishal Bali have earlier worked together in Wockhardt Hospitals and Fortis. 19
4 2 CO-FOUNDERS & EXECUTIVE DIRECTORS OF CTSI Joe Nicholas Andrew Shogan 2. The group is constructing a 200-bed oncology hospital in Bangladesh along with AFC Healthcare. first centre in Hyderabad. The company was also co-founded by Joseph Nicholas and Andrew Shogan- the duo relocated to India from the US to launch CTSI in the region and to expand its network. TPG is one of the leading global investors in healthcare and for TPG Growth this was its third healthcare/med-tech investment out of India. In September 2013, the fund had made a minority investment of Rs 145 crore in Sutures India, a manufacturer of medical consumables. It has grown that platform exponentially beyond India and now owns 52% of the company. TPG Growth also owns 29% stake in Asiri Healthcare, Sri Lanka. TPG Growth s investment in CTSI was on the back of its thesis around single speciality healthcare delivery platform. "With rising incidence of cancer in the region, more than 7 million cancer patients are expected to suffer from the disease in India alone by 2020 which demand the establishment of more comprehensive cancer care centres. TPG perceived the investment in CTSI as an opportunity to craft a high quality integrated oncology programme as well as be the architect of a network of oncology centres in India and other countries of south-east Asia," explains Bali. TPG realised this as a scope to create a brand under AOI that had its roots in the quality standards of a university level oncology delivery programme, UPMC in this case. A diverse strategy to erect a differentiator in oncology care was fleshed out during the investment process. The yawning demand supply gap in cancer treatment was the centre piece of this strategy. We wanted to carve out a brand that introduced US-based protocol driven oncology care in India, as the US has always been at the forefront of oncology care in the world, whether it is clinical competence, technology or research, says Bali. Also, AOI wanted to constitute a treatment planning system and an international tumour board of repute, both of which have a significant role to play in treatment outcomes. Today, I can proudly state that we have the best international tumour board in the country, helmed by clinical experts from the UPMC, says Bali. Another USP of AOI is the centralised radiation treatment planning (CTP) system that is buoyed by an internationally trained team of radiation oncologists, medical physicists and dosimetrists, based at the hub centre in Hyderabad, who support the treating oncologists with the most 20
5 effective radiation therapy course of cancer treatment for patients within the AOI network. The CTP is powered by a decision support system software to ensure uniformity of care. Prior to TPG Growth s majority investment, AOI had merely two functional cancer facilities in India- one nestled in the 300-bed Citizens Hospital in Hyderabad and another chemotherapy OPD centre at Vijayawada s Andhra Hospital. A comprehensive cancer centre with radiation therapy at the 200-bed NRI Medical College, Guntur, Andhra Pradesh was under way. In the last one year, AOI has rapidly expanded its footprint across India and has a pipeline of projects in south Asia which are under implementation. Besides launching the centre at NRI Medical College, in December last year, it commenced operations of an 80-bed dedicated oncology centre at Royal Care Super Speciality Hospital in Coimbatore. Around two months back, it started a dedicated oncology block with medical, surgical and radiation oncology at the reputed Dayanand Medical College & Hospital in Ludhiana. Coming up next is a 100-bed oncology and specialty hospital in Nagpur, spread over 90,000 square feet which would serve the entire Vidharbha region of Maharashtra. The hospital in Nagpur is in association with the Cure All Group, promoted by the Nangia Family. This would be a comprehensive oncology hospital offering radiation, medical and surgical oncology services. This project, with a budget of $ 4.5 million (Rs 30 crore) is slated to be commissioned in the month of August, says Dr Lloyd Nazareth, who was designated as group CEO for CTSI at the time of announcing the TPG investment. Now Joseph Nicholas and Andrew 3. Citizens Hospital has shown 50% growth in revenue over the last one year. 3 21
6 4. AOI recently started operations in Ludhiana. 4 Shogan have taken over as executive directors and continue to spearhead the expansion of the company, besides bridging and contributing to knowledge of oncology systems from the US. In the last few months, AOI has also been fortifying its presence pan Asia. AOI has signed an MoU with AFC Healthcare to start a 200-bed oncology hospital at Chittagong in Bangladesh. AFC Healthcare has also been instrumental in starting Bangladesh s leading cardiac centre, Fortis Escorts Heart Institute, at Khulna. The oncology hospital would be a Greenfield project built ground up. The total cost of the project, which is funded by AFC, exclusive of the land, is to the tune of $25 million (Rs 165 crore). AOI has also inked a deal with Asiri Hospitals, a TPG Growth portfolio company, to launch the country s first comprehensive cancer care centre in the private sector at the Asiri Surgical Hospital. The Asiri - AOI oncology hospital would have the country s first radiation therapy in the private sector, says Bali. AOI is also expected to start a Greenfield project in Myanmar with a group that is currently into multi specialty hospitals. But that project has been plagued by delay. The Myanmar government has fairly stringent rules on foreign investment. TPG has other investments in that country and we are hopeful of closing the deal in a few months, explains Bali. And in Nepal, AOI has tied up with a group to construct an oncology hospital with a local business family. Scouting for projects in UP, MP, Maharashtra, Punjab-Haryana and eastern India, AOI is inching towards closing around 12 to 13 more projects by the end of this year. We have planned to remain focused on having around 15 centres in India and south-east Asia by the next three years, shares Dr Lloyd. In India, the group has an opportunity to expand the network in Punjab in association with Dayanand Medical College & Hospital. They have expressed interest, but the talks with the trust are in a preliminary stage, says Dr Lloyd. Additionally, Maharashtra is another state that the group has zeroed in onwhether it is Mumbai, Navi Mumbai, Pune or Nashik. The group is likely to forge a few partnerships in Maharashtra within the next few months. Yes, we have a strategic interest in Maharashtra. First, there is an under-served market in oncology there and second, the clinical talent is looking for better infrastructure. Mumbai-Navi Mumbai has a population of 25 million people and the city has just a few quality cancer care centres, informs Dr Lloyd. Additionally, the group has lined up a standalone 100-bed oncology hospital in Bhubaneswar. Out of Rs 220 crore that TPG Growth was slated to invest in CTSI, a majority has already been pumped in. Investment in CTSI has all gone in as growth capital, says Bali, adding, We would continue to invest 22
7 5 in CTSI as and when it is required. And how does the group single out potential markets? We look at the quality of clinical talent available locally, how well developed is the state, the number of organised healthcare players and the addressable population, says Dr Lloyd. As of now, the spotlight of the group is on India and its tier I and tier II cities. Around 70% of our focus would always be on India, says Bali. The vehicle for growth for AOI is primarily the partnership model with existing healthcare players. According to Bali, the partnership model accelerates the scale for AOI. There are many multi specialty hospitals in the country which do not have oncology services. With AOI, they can establish a high quality internationally benchmarked oncology programme for their patients, says he. What AOI brings to a partnership is its international expertise of clinical protocols, the expertise in design, equipment and training, financial investment in technology and the operational expertise to run a high quality oncology centre. And how does AOI sieve out the partners? Our aim is to opt for long-term partnerships. We need to have shared vision with the partner with respect to following international protocols and quality of services in oncology. We also prefer tying with partners who have presence in healthcare and thus possess an understanding of how the industry functions, says Dr Lloyd. For instance, to provide high quality radiation services, AOI has benchmarked that a single Linac should not take on more than patients per day, while several centres in India go up to 100 patients. The centralised treatment planning service gives the group enhanced productivity. As the AOI network expands, we are pleased to see a number of institutions across the country which are proactively reaching out to us for forging partnerships, says Dr Lloyd. One of the core strategies of expansion is establishing oncology centres with focus on radiation therapy and medical oncology services. In centres where the partnership is with a multi speciality hospital, surgical oncology continues to be provided by them. The centres with medical and radiation oncology services are housed in buildings with an in-built are of 20,000 to 25,000 square feet. Its investment per centre can range from $ 2 million (Rs 13 crore) to $ 5 million (Rs 33 crore) based on the level of technology and infrastructure 5. The group's facility at NRI Medical College, Guntur. 23
8 6 6. The target for CTSI is to take the total revenue of the group from Rs 150 crore to Rs 240 crore in FY requirement. Every centre of AOI necessarily has radiation and PET scan services. The investment shoots up when surgical oncology services are provided as well. Usually, the unit should attain operational breakeven within two years, says Dr Lloyd. Ever since the TPG investment, the management team has also been augmented across operations and other key functions to shore up the geographical expansion and to ensure the deliverables at each centre. CTSI s second arm, the Hyderabad based Citizens Hospital, has also seen a major spurt in revenue after TPG s takeover. The revenue has swelled by 50% in the last one year, mainly due to strengthening of a few specialties besides surgical oncology like cardiology, gastroenterology, orthopaedics, neurosciences and emergency care. Post the investment, Citizens has become a dominant specialty hospital in the Hyderabad s competitive healthcare ecosystem. The hospital has attracted many senior and respected clinicians within the city across all specialities which demonstrates the clinical orientation of the group. What was an impediment in terms of its location has become an advantage with most of the new housing of Hyderabad coming up in that region of Hyderabad, says Dr Lloyd. And CTSI s pathology provider, AmPath, has also spread its wings in the last one year. It has started operations in Lucknow, Kolkata, Patna, Chennai and doubled its revenue over the last one year. Also, it has tied up with TPG s other invested company, Motherhood Hospitals, to start a lab in each of its centres. AmPath now intends to increase its B2B business, delve into B2C and start four more satellite labs in key geographies, says Dr Lloyd. How the well-crafted strategies are panning out? The brand is growing at a steady pace and the target for CTSI is to take the total revenue of the group from Rs 150 crore to Rs 240 crore in FY , says Dr Lloyd. But would CTSI able to sustain its growth, in the wake of stringent government regulations for private healthcare? The macro environment for healthcare services will change in India, given the government s push and regulatory policies. Regulation should support the industry to grow and has to be well planned and executed, so that the private sector continues to invest in infrastructure and introduces advanced medical technologies. I am optimistic that the government will play an enabling role, concludes Bali. 24
R e s e a r c h S t r a t e g y
Sheffield Teaching Hospitals NHS Foundation Trust Academic Directorate of Specialised Cancer R e s e a r c h S t r a t e g y Academic Directorate of Specialised Cancer Research Strategy Executive Summary
More informationAgenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK
Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK 1. Introduction 1.1. Alzheimer s Research UK is the UK s leading dementia research charity. As research experts,
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and
More information[Justice Chao Hick Tin], Justice Tan Siong Thye, Distinguished. Guests, Friends of the Singapore Mediation Centre, Ladies and
WELCOME ADDRESS BY THE HONOURABLE JUSTICE BELINDA ANG SAW EAN, CHAIRPERSON, SINGAPORE MEDIATION CENTRE AT SMC S ANNUAL APPRECIATION LUNCH ON FRIDAY, 1 AUGUST 2014, AT 12:30PM AT THE INTERCONTINENTAL HOTEL
More informationVision. Mission. Hopelink s Values. Introduction. A community free of poverty
Vision A community free of poverty Mission Hopelink s mission is to promote self-sufficiency for all members of our community; we help people make lasting change. Hopelink s Values Growth and Human Potential
More informationABOUT. CIEL Healthcare Limited ( CHL ), a subsidiary of CIEL Limited, is a Mauritian registered private limited
FACTSHEET ABOUT CIEL Healthcare Limited ( CHL ), a subsidiary of CIEL Limited, is a Mauritian registered private limited company, with a prime objective to own, operate and manage assets in the healthcare
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationUC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN
UC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN 2016-2020 1 2 OUR VISION Excellence in research is at the core of our vision for UC-Health Research Institute (HRI) which brings together critical mass in biomedicine,
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationStrategic Plan Executive Summary Society for Research on Nicotine and Tobacco
Strategic Plan 2013 2017 Executive Summary Society for Research on Nicotine and Tobacco Prepared By: Corona Insights Corona Insights, 2012 CoronaInsights.com CONTENTS Introduction... 1 Background... 1
More informationPRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER
PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER This collaboration creates the world s first clinically reliable and
More informationLondon Regional Cancer Program
London Regional Cancer Program Table of Contents Mission, Vision and Values...1 Key Areas and Directions... 2 Leading in Patient Care and Service Delivery... 2 Improving Quality and Safety... 5 Strengthening
More informationSTRATEGIC PLAN
2019-2022 STRATEGIC PLAN Thank you for your interest in our work! On behalf of The Friends staff and board of directors, we are excited to share our 2019-2022 Strategic Plan with you. This document represents
More informationPartnering for Growth
Partnering for Growth JP Morgan Healthcare Conference Simon Lowth, Chief Financial Officer, AstraZeneca 9 January 2013 Partnering for Growth Agenda Our platforms for growth Partnering strategy and capabilities
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationStrategic Directions
Strategic Directions 2015-2019 Peter MacCallum Cancer Centre Strategic Directions 2015-2019 THE BEST IN CANCER CARE We are a cancer centre unsurpassed in the world, where humanity, caring service and relentless
More informationPROVIDENT PERSPECTIVE October 2017
PROVIDENT PERSPECTIVE October 2017 Private Equity Investment in Dental Care Creating Long Term Value Dental is a sector that has long been a favorite of the private equity community. Consolidation within
More information2015 Investor Conference
2015 Investor Conference ACCELERATING PROFITABLE GROWTH Jill Schaaf President, Renal Care Teeramanas Tanaekakarapong, ESRD Patient, Bangkok, Thailand Becoming The Global Leader In Renal Care Our Global
More informationDelivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental
Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers
More informationPPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM
HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures
More informationTRANSFORM CANCER SERVICES
WORKING TOGETHER to TRANSFORM CANCER SERVICES in SOUTH EAST WALES 1 Understanding the context Cancer survival rates are increasing. But the number of people getting cancer is increasing too. At Velindre
More informationImaging Systems. Gene Saragnese EVP and GM Imaging Systems
Imaging Systems Gene Saragnese EVP and GM Imaging Systems 1 Imaging Systems Strategy Drive Customer & Patient Experience Quality, reliability and service delivery Ease of use, speed, comfort, dose Deliver
More informationType 1 Research Today
Type 1 Research Today A healthy landscape for supporting type 1 diabetes research jdrf.org.uk UK funding organisations are investing close to 100 million in type 1 research This is testament to the quality
More informationGlobal EHS Leaders Survey 2018: EHS Consulting Brands
Global EHS Leaders Survey 2018: EHS Consulting Brands N O V E M B E R 2 0 1 8 W W W. V E R D A N T I X. C O M Global EHS Leaders Survey 2018: EHS Consulting Brands This report helps strategy leaders, chief
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More information29 October For immediate release MEDIA RELEASE
29 October 2009 For immediate release MEDIA RELEASE EXPECTANT MOMS, BABIES SUBJECTS OF NEW STUDY TO FIND WAYS TO PREVENT OBESITY AND DIABETES - Official launch of Growing Up in Singapore Towards healthy
More informationNHS Healthcare Science. Cumbria & NE LWAB. 4 th September 2018
NHS Healthcare Science Cumbria & NE LWAB 4 th September 2018 Executive Summary The Business Proton Partners International (PPI) will build, own and operate a network of Proton Beam Therapy Cancer Centres
More informationBlood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
More informationWilliam Blair 30 th Annual Growth Stock Conference
William Blair 30 th Annual Growth Stock Conference June 2010 Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of the safe harbor provisions of the
More informationCochlear Limited 2017 Annual General Meeting Chairman s Address
Cochlear Limited 2017 Annual General Meeting Chairman s Address 17 October 2017 Rick Holliday-Smith Chairman Ladies and gentlemen Financial results Cochlear reported a record net profit of $224 million,
More informationProgram Priorities 2018
Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term
More informationPosition Profile Chief Executive Officer Feeding America San Diego San Diego, CA
Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA Feeding America San Diego is seeking an experienced and inspirational Chief Executive Officer to lead this impactful and
More informationFor personal use only
ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan
More informationGOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4
GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services
More informationReport to the GAVI Alliance Board 7-8 July 2011
Report to the GAVI Alliance Board 7-8 July 2011 Subject: Report of: Authored by: GAVI Matching Fund for Immunisation David Ferreira, MD, Innovative Finance Paolo Sison, Director, Innovative Finance Agenda
More informationLifeHealthcare Investor Day 5 October 2016
LifeHealthcare Investor Day 5 October 2016 Agenda 1. Lunch and Welcome 2. LifeHealthcare Overview and Update on Strategic Priorities 3. Spine Overview 4. Dr Hsu Presentation 5. Orthopaedics Overview 6.
More informationStrategic Plan
YMCA of Whittlesea Healthier, happier, connected communities Strategic Plan 2013-2018 For more than 25 years, the YMCA of Whittlesea has been dedicated to strengthening people and the community. Today
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationTreatments of tomorrow: dementia research and drug discovery. Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK
Treatments of tomorrow: dementia research and drug discovery Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK More failure What is different about dementia drug discovery? The
More informationREPORT. A Model Clinical Trials System for the 21st Century
www.georgiacore.org www.georgiacancertrials.org REPORT A Model Clinical Trials System for the 21st Century A Response to the Institute of Medicine s 2010 Report A National Cancer Clinical Trials System
More informationThe Ayrshire Hospice
Strategy 2010-2015 Welcome... The Ayrshire Hospice : Strategy 2010-2015 Index 05 06 08 09 10 12 15 17 19 Foreword Our vision and purpose Our guiding principles Our achievements 1989-2010 Our priorities
More information### About Bharat Biotech
Press Release Bharat Biotech Bharat Biotech Launches Typbar-TCV, world s first clinically proven typhoid conjugate vaccine for infants 6 months & older and Adults The new vaccine brings hope to millions
More informationChampioning patients every step of the way
Championing patients every step of the way The majority of people living with a rare disease have no treatment for their condition. At Shire, we have long believed we have a unique opportunity to champion
More informationGenomic Health. Kim Popovits, Chairman, CEO and President
Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and
More informationSUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS
Health & Life Sciences SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS A CROSS-SECTOR APPROACH TO DIET-RELATED CHRONIC DISEASE A breakfast discussion as part of Oliver Wyman s participation in
More informationQUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010
QUALITAS MEDICAL GROUP LIMITED CORPORATE PRESENTATION January 2010 Contents Our Business Corporate Developments Growth Strategies Financial Highlights Summary Business Overview Who We Are Established in
More informationInsights into the Indian Dental World
Presentation to Mentors of Dental GPS India Insights into the Indian Dental World Mumbai, September 30, 2015 Trusted Advisory Services in ASEAN and India Indian Dental Landscape Number of Clinics 150,000
More informationWednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address
Advanced Molecular Diagnostic Systems The Walter and Eliza Hall Biotechnology Centre, 4 Research Avenue, La Trobe R&D Park, Bundoora, Victoria 3083 T: +61 (0)3 9345 2127 F: +61 (0)3 9345 2242 Wednesday
More informationFAMILY & CHILDREN S SERVICES STRATEGIC PLAN
2014-2019 FAMILY & CHILDREN S SERVICES STRATEGIC PLAN WHO WE ARE Family & Children s Services is a leading provider of behavioral health care and family services for people of all ages in Tulsa and surrounding
More informationTotal Face Group Limited
Total Face Group Limited 2017 Half Year Results Presentation Contents Results Highlights Highlights Half Year Results Revenue Bridge Revenue Breakdown Clinic Profitability Profit & Loss Financial Position
More informationSAVING LIVES: ACHIEVING MORE
SAVING LIVES: ACHIEVING MORE ANTHONY NOLAN ORGANISATIONAL STRATEGY FOR 2015-2018 WHERE WE RE COMING FROM In 1974, we were the world s first stem cell donor register. And over 40 years later, we re at the
More informationThe Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative
The Value of Product Development Partnerships in Vaccine Innovation Hansi J. Dean International AIDS Vaccine Initiative The Product Development Partnership Model A non-profit partnership of public and
More informationTRUSTED PHYSIOTHERAPY CARE PARTNER
Best physiotherapy care for your patients o Improving outcomes o Creating superior patient experience TRUSTED PHYSIOTHERAPY CARE PARTNER 1 ReLiva: Introduction ReLiva is a leading chain of physiotherapy
More informationResults Based Advocacy to Increase Access Marie Stopes International
to Increase Access Marie Stopes International Women don t lease their bodies from the state or church, they own them. Founder, Tim Black (1937 2014) Almost all of the health services we provide throughout
More informationTissue Engineering Market Analysis, Size, Share, Growth, Industry Trends and Forecast to Hexa Research
Tissue Engineering Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 - Hexa Research " The global tissue engineering market was valued to be around USD 23.2 billion in 2015 and
More informationStrategic Plan
Strategic Plan 2013-2018 Strategic Plan 2013-2018 Contents The Challenges of an Aging Population.. Baycrest: fulfilling a legacy of commitment and accomplishment Looking Ahead: dedicated to serve our local
More informationOPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES
OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES Dr. Robert P. Kadlec Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services 2017 Chemical and
More informationPhotocure ASA Executing the Strategy
Photocure ASA Executing the Strategy NOVEMBER 2012 ERIK DAHL, CFO KATHLEEN DEARDORFF, COO Disclaimer The information included in this Presentation contains certain forward-looking statements that address
More informationMomentum Awards: Institutional pumppriming awards for dementia research
Momentum Awards: Institutional pumppriming awards for dementia research The purpose of this rapid action call is to boost the UK research base in biomedical science, in readiness for the new UK Dementias
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
More informationService Improvement - Strategic. Service Improvement - Strategic. Regional Oncology Communications and Health Promotions
Service Improvement - Strategic Service Improvement - Strategic Regional Oncology Communications and Health Promotions Development of Radiation Oncology Services The evaluation process for the development
More informationSaving & Enriching Lives
Saving & Enriching Lives 1 At A Glance Our Logo Our Vision & Values Our Growth Story Our Unit - Fortis Hospital & Kidney Institute 2 At a glance Fortis Healthcare Limited is a leading integrated healthcare
More informationFor personal use only
Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development
More informationHILLENBRAND INDUSTRIES INC
HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518
More informationLetter to Shareholders SEMI-ANNUAL REPORT 2008
Letter to Shareholders SEMI-ANNUAL REPORT 2008 Dear Shareholder You have in your hand the first shareholder letter issued by Nobel Biocare. Thanks to the conversion of Nobel Biocare s bearer shares into
More informationThe Dental Corporation Opportunity
The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,
More informationMedicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, Kamau Chionesu
Medicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, 2017 Kamau Chionesu kamau.chionesu02@uwimona.edu.jm Questions 1. What are the likely key requirements for successful participation
More informationIntercell and Novartis form world leading strategic partnership to drive vaccines innovation
Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell
More informationLEADERS IN SPORT COLLEGE OF SPORT AND EXERCISE SCIENCE
LEADERS IN SPORT World leading facilities, in excess of $127 million across several campuses Over 40 vocational education, undergraduate and postgraduate programs across the university in the sport category
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationR&D Status in Romania
R&D Status in Romania Romania Economy is the second largest country in the Central and Eastern Europe (after Poland); it has a population of 22 million people; it benefits from a strategic geographic position;
More informationMeeting the MDGs in South East Asia: Lessons. Framework
Meeting the MDGs in South East Asia: Lessons and Challenges from the MDG Acceleration Framework Biplove Choudhary Programme Specialist UNDP Asia Pacific Regional Centre 21 23 23 November 2012 UNCC, Bangkok,
More informationMental Health Matters
www.stpatricks.ie Mental Health Matters 2013 2018 Empowering Recovery st patrick s mental health services Empowering recovery St. Patrick s Mental Health Services Mental Health Matters 2013 2018 strategy
More informationTHE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING
CITY OF CARDIFF COUNCIL CYNGOR DINAS CAERDYDD EXECUTIVE PUBLIC SERVICES BOARD: 10 TH MARCH 2017 THE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING
More informationWhy Kenya is fast becoming an African centre of medical excellence
Why Kenya is fast becoming an African centre of medical excellence If you re responsible for health cover for staff based in Kenya, the good news is that local health insurance is now a much more viable
More informationNEWSLETTER June Summer greetings from Follicum
NEWSLETTER June 2018 Follicum hopes that this newsletter reaches as many of the company's owners and stakeholders as possible. If you wish to follow our continued development, please register your e-mail
More informationInnovator Case Studies: Oncology Networks
Innovator Case Studies: Oncology Networks J. Ike Nicoll Chief Executive Officer Cancer Clinics of Excellence Alan Armer, Ph.D. Vice President, Research & Development Catholic Health Initiatives Cancer
More informationSAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
More informationGAVI, THE VACCINE ALLIANCE
#vaccineswork GAVI, THE VACCINE ALLIANCE Natasha Bilimoria December 2016 National Academy of Sciences www.gavi.org 1 ABOUT GAVI Gavi s mission: to save children s lives and protect people s health by increasing
More informationPROGRESS UPDATE. The Pan-Mass Challenge
PROGRESS UPDATE The Pan-Mass Challenge Fall 2017 PAN-MASS CHALLENGE: HITTING A HIGHER GEAR IN THE FIGHT AGAINST CANCER For nearly four decades, the Pan-Mass Challenge (PMC) and Dana- Farber Cancer Institute
More informationDIGITAL DIABETES CARE MARKET READY TO TAKE OFF
DIGITAL DIABETES CARE MARKET 2018-2022 READY TO TAKE OFF www.research2guidance.com A market study about diabetes apps, connected devices, and services 3 rd edition, 3 rd September 2018 Research2Guidance
More informationCOMPANY PROFILE. AL SHAMS Group
COMPANY PROFILE AL SHAMS Group Al Shams Pharma Scintific Bureau Shams Al-Ibdaa Drug Store Bilim Pharma Co. Al-Shams Drug Store Al-Murjan Drug Store Al-Aqsa Pharmacy & Cosmetic Al-Khadraa Pharmacy & Cosmetic
More informationAStoryofSunPharmaceuticalsLaboratoriesGoingGlobal
Global Journal of HUMANSOCIAL SCIENCE: E Economics Volume 18 Issue 4 Version 1.0 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Online ISSN: 2249460x & Print
More informationFORM8-K HILLENBRAND,INC.
UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): December18,2015
More informationThis is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market
More information2. The role of CCG lay members and non-executive directors
CCG Lay Members, Non-Executive Directors and STP Governance and Engagement 1. Introduction Report from network events organised by NHS England and NHS Clinical Commissioners in February 2017 This briefing
More informationThe Way Ahead Our Three Year Strategic Plan EVERY MOMENT MATTERS
The Way Ahead Our Three Year Strategic Plan 2017-2020 EVERY MOMENT MATTERS Every moment matters - that s what our logo says right next to our name John Taylor Hospice and for us the two are inseparable.
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationWellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries.
IABC Wellington: Membership Marketing work plan 2015 Context Wellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries. IABC Wellington is a
More informationStrategic Planning For Oncology Services And Why It Is So Vital In Our Current Environment
Strategic Planning For Oncology Services And Why It Is So Vital In Our Current Environment Please stand by. The webinar will begin shortly. Strategic Planning For Oncology Services And Why It Is So Vital
More informationECOMMERCE PLATFORM IMPLEMENTATIONS ON SAP HYBRIS
ECOMMERCE PLATFORM IMPLEMENTATIONS ON SAP HYBRIS The top-rated SAP Hybris commerce platform helps businesses sell more goods, services and digital content globally through every touchpoint, channel and
More informationThe MGH Journey. Shaping the Future of an Entire Region
The MGH Journey Shaping the Future of an Entire Region Navigating History, Building on Our Past Northwestern Hospital 1890 First General 1896 St. Luke s 1897 New St. Luke s opens 1915 Northern Michigan
More informationGavi s private sector engagement approach
Gavi s 2016-2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 Geneva, Switzerland Reaching further, together www.gavi.org A HISTORY
More informationForeword. Our shared principles
Our Digital Future Foreword The way we manage our lives is changing. 86% of households now have internet access, 82% of people go online every day and 72% of adults use a smartphone 1. It is now time to
More informationAmeya works predominantly in the architectural design, interiors and project management segments in healthcare industry
Introduction Ameya design is premier health care consultancy firm with experience with design and execution of largest number of private sector health care facility in India. Key Information Ameya works
More informationLiquid Biopsies. Next Generation Cancer Molecular Diagnostics
Liquid Biopsies Next Generation Cancer Molecular Diagnostics Forward Looking Statements 2 Statements pertaining to future financial and/or operating results, future research, diagnostic tests and technology
More informationWelcome. A Legacy of Success. Brighter Futures Together
Welcome I welcome you to the publication of our Strategic Plan 2015 2018 Brighter Futures Together on behalf of the Board of Kerry Diocesan Youth Service [KDYS]. A Legacy of Success The Diocese of Kerry
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More information